Isemid

RSS

Torasemide

Authorised
This medicine is authorised for use in the European Union.

Overview

Isemid is a veterinary medicine used to treat signs related to congestive heart failure in dogs. Congestive heart failure is a condition when the heart cannot pump enough blood around the body. This can lead to exercise intolerance (inability to carry out physical activity), difficulty breathing and fluid retention. Isemid contains the active substance torasemide.

This EPAR was last updated on 07/02/2019

Authorisation details

Product details
Name
Isemid
Agency product number
EMEA/V/C/004345
Active substance
Torasemide
International non-proprietary name (INN) or common name
Torasemide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QC03CA04
Publication details
Marketing-authorisation holder
CEVA Santé Animale
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
09/01/2019
Contact address

10 avenue de la Ballastiere
33500 Libourne
France

Product information

09/01/2019 Isemid - EMEA/V/C/004345 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • CARDIOVASCULAR SYSTEM
  • HIGH-CEILING DIURETICS
  • plain sulfonamides

Therapeutic indication

For treatment of clinical signs related to congestive heart failure in dogs, including pulmonary oedema.

Assessment history

How useful was this page?

Add your rating